{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:09:06Z","timestamp":1788883746970,"version":"build-2803163510"},"reference-count":20,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,26]]},"DOI":"10.1182\/bloodadvances.2025016480","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T17:19:03Z","timestamp":1750871943000},"page":"4306-4310","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2937-1705","authenticated-orcid":false,"given":"Robbe","family":"Heestermans","sequence":"first","affiliation":[{"name":"1Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium"},{"name":"2Department of Hematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium"},{"name":"3Department of Clinical Biology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6193-2296","authenticated-orcid":false,"given":"Catharina","family":"Olsen","sequence":"additional","affiliation":[{"name":"4Brussels Interuniversity Genomics High Throughput Core, Vrije Universiteit Brussel, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium"},{"name":"5Clinical Sciences, Research Group Genetics, Reproduction and Development, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium"},{"name":"6Interuniversity Institute of Bioinformatics, Universit\u00e9 Libre de Bruxelles, Vrije Universiteit Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervine","family":"Ameli","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Succari","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-3906","authenticated-orcid":false,"given":"Toon","family":"Janssen","sequence":"additional","affiliation":[{"name":"4Brussels Interuniversity Genomics High Throughput Core, Vrije Universiteit Brussel, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6012-5540","authenticated-orcid":false,"given":"Wouter","family":"De Brouwer","sequence":"additional","affiliation":[{"name":"1Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium"},{"name":"2Department of Hematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-8708","authenticated-orcid":false,"given":"Ann","family":"De Becker","sequence":"additional","affiliation":[{"name":"1Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium"},{"name":"2Department of Hematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Vande Broek","sequence":"additional","affiliation":[{"name":"7Department of Oncology and Hematology, VITAZ Hospital, Sint-Niklaas, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0863-3369","authenticated-orcid":false,"given":"Marleen","family":"Bakkus","sequence":"additional","affiliation":[{"name":"1Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium"},{"name":"3Department of Clinical Biology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Schots","sequence":"additional","affiliation":[{"name":"1Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium"},{"name":"2Department of Hematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4012-4617","authenticated-orcid":false,"given":"Elke","family":"De Bruyne","sequence":"additional","affiliation":[{"name":"1Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3662-4347","authenticated-orcid":false,"given":"Ivan","family":"Van Riet","sequence":"additional","affiliation":[{"name":"1Translational Oncology Research Center, Team Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium"},{"name":"2Department of Hematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"33","key":"2025082608315253800_bib1","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","article-title":"Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma","volume":"33","author":"Walker","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"2025082608315253800_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2010-04-279539","article-title":"Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma","volume":"117","author":"Walker","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2025082608315253800_bib3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2016-02-698092","article-title":"Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes","volume":"128","author":"Kort\u00fcm","year":"2016","journal-title":"Blood"},{"key":"2025082608315253800_bib4","doi-asserted-by":"crossref","first-page":"979569","DOI":"10.3389\/fonc.2022.979569","article-title":"Aberrant DNA methylation in multiple myeloma: a major obstacle or an opportunity?","volume":"12","author":"Muylaert","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"2025082608315253800_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1078-0432.CCR-22-1161","article-title":"Single-nucleotide variants and epimutations induce proteasome inhibitor resistance in multiple myeloma","volume":"29","author":"Haertle","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"18","key":"2025082608315253800_bib6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.2020010452","article-title":"Cereblon enhancer methylation and IMiD resistance in multiple myeloma","volume":"138","author":"Haertle","year":"2021","journal-title":"Blood"},{"issue":"3","key":"2025082608315253800_bib7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s41375-019-0587-5","article-title":"DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma","volume":"34","author":"Choudhry","year":"2020","journal-title":"Leukemia"},{"issue":"11","key":"2025082608315253800_bib8","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s43018-023-00646-4","article-title":"Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation","volume":"4","author":"Derrien","year":"2023","journal-title":"Nat Cancer"},{"issue":"1","key":"2025082608315253800_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13148-018-0597-6","article-title":"Distinct promoter methylation profile reveals spatial epigenetic heterogeneity in 2 myeloma patients with multifocal extramedullary relapses","volume":"10","author":"Yao","year":"2018","journal-title":"Clin Epigenetics"},{"issue":"1","key":"2025082608315253800_bib10","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1038\/s41467-022-32145-y","article-title":"The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states","volume":"13","author":"Rasche","year":"2022","journal-title":"Nat Commun"},{"issue":"19","key":"2025082608315253800_bib11","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.3390\/cancers14194901","article-title":"Liquid biopsy-derived DNA sources as tools for comprehensive mutation profiling in multiple myeloma: a comparative study","volume":"14","author":"Heestermans","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2025082608315253800_bib12","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.3390\/ijms25105208","article-title":"Liquid biopsies as non-invasive tools for mutation profiling in multiple myeloma: application potential, challenges, and opportunities","volume":"25","author":"Heestermans","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2025082608315253800_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41409-022-01887-0","article-title":"DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma","volume":"58","author":"D'Souza","year":"2023","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"2025082608315253800_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"Liu","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"2025082608315253800_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13045-022-01327-y","article-title":"Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma","volume":"15","author":"Chiu","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"24","key":"2025082608315253800_bib16","doi-asserted-by":"crossref","first-page":"e70477","DOI":"10.1002\/cam4.70477","article-title":"5-hydroxymethylcytosine profiles of cfDNA in urine as diagnostic, differential diagnosis and prognostic markers for multiple myeloma","volume":"13","author":"Xie","year":"2024","journal-title":"Cancer Med"},{"issue":"10","key":"2025082608315253800_bib17","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/sj.leu.2403434","article-title":"DNA methylation changes in multiple myeloma","volume":"18","author":"Galm","year":"2004","journal-title":"Leukemia"},{"issue":"17","key":"2025082608315253800_bib18","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1158\/0008-5472.CAN-10-0282","article-title":"DNA methylation analysis determines the high frequency of genic hypomethylation and low frequency of hypermethylation events in plasma cell tumors","volume":"70","author":"Salhia","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"2025082608315253800_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43556-024-00188-w","article-title":"Multiple myeloma: signaling pathways and targeted therapy","volume":"5","author":"Lu","year":"2024","journal-title":"Mol Biomed"},{"issue":"1","key":"2025082608315253800_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41408-023-00817-7","article-title":"Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma","volume":"13","author":"Evers","year":"2023","journal-title":"Blood Cancer J"}],"updated-by":[{"DOI":"10.1182\/bloodadvances.2026021127","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000}},{"DOI":"10.1182\/bloodadvances.2026021127","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000}}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/16\/4306\/2407793\/blooda_adv-2025-016480-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/16\/4306\/2407793\/blooda_adv-2025-016480-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T12:31:59Z","timestamp":1756211519000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/16\/4306\/537933\/Blood-derived-cell-free-DNA-is-a-superior"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":20,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,8,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016480","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,26]]},"published":{"date-parts":[[2025,8,18]]}}}